• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    BitNile Holdings Reports Second Quarter 2022 Financial Results

    8/23/22 6:30:00 AM ET
    $ALZN
    $NILE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $ALZN alert in real time by email

    BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), reported its financial results for the second quarter ended June 30, 2022 on its Form 10-Q filed with the Securities and Exchange Commission.

    Second quarter 2022 highlights include:

    • Total assets of $596.3 million as of June 30, 2022;
    • Positive working capital of $51.4 million as of June 30, 2022;
    • Cash and cash equivalents of $24.1 million as of June 30, 2022;
    • Revenue from cryptocurrency mining of $4.0 million, compared to $0.3 million in the prior second fiscal quarter;
    • Revenue from hotel operations of $4.6 million, compared to $0 in the prior second fiscal quarter;
    • Revenue from lending and trading activities of $0.9 million, compared to $53.3 million in the prior second fiscal quarter, of which revenue in the prior year second fiscal quarter included an approximate $40 million unrealized gain from the Company's investment in Alzamend Neuro, Inc. (NASDAQ:ALZN);
    • Revenues from trading activities during the three months ended June 30, 2022 included net gains on equity securities, including unrealized gains and losses from market price changes. These gains and losses have caused, and will continue to cause, significant volatility in our periodic earnings;
    • Total revenue of $17.4 million, a decrease of 72%, from $62.1 million in the prior second fiscal quarter; and
    • Net loss available to common stockholders of $25.8 million, compared to net income available to common stockholders of $42.2 million in the prior second fiscal quarter.

    Six months ended June 30, 2022 highlights:

    • Revenue from cryptocurrency mining of $7.5 million, compared to $0.4 million in the prior six-month period;
    • Revenue from hotel operations of $7.3 million, compared to $0 in the prior six-month period;
    • Revenue from lending and trading activities of $18.9 million, a decrease of 68%, from $58.5 million in the prior six-month period;
    • Revenue of $50.2 million, a decrease of 33%, from $75.4 million in the prior six-month period;
    • Interest expense of $31.9 million primarily resulting from the issuance of $66 million of secured promissory notes in December 2021, which were fully paid in March 2022. Interest expense from these notes included the amortization of debt discount of $26.3 million from the issuance of warrants, a non-cash charge, and original issue discount, in connection with these secured promissory notes; and
    • Net loss available to common stockholders of $54.6 million compared to net income available to common stockholders of $44.2 million in the prior six-month period.

    Revenues

    Revenues by segment for the six months ended June 30, 2022 and 2021 were as follows:

    For the Six Months Ended June 30,

    Increase

    2022

    2021

    (Decrease)

    %

    Gresham Worldwide, Inc. ("GWW")

    $

    13,748,000

    $

    12,825,000

    $

    923,000

     

    7

    %

    TurnOnGreen, Inc. ("TurnOnGreen")

     

    2,191,000

     

    3,213,000

     

    (1,022,000

    )

    -32

    %

    BitNile, Inc. ("BNI")

     

     

     

     

    Revenue, cryptocurrency mining

     

    7,524,000

     

    421,000

     

    7,103,000

     

    1687

    %

    Revenue, commercial real estate leases

     

    550,000

     

    281,000

     

    269,000

     

    96

    %

    Ault Global Real Estate Equities, Inc.

     

    7,296,000

     

    -

     

    7,296,000

     

    —

     

    Ault Alliance, Inc. ("Ault Alliance"):

     

     

     

     

    Revenue, lending and trading activities

     

    18,864,000

     

    58,485,000

     

    (39,621,000

    )

    -68

    %

    Other

     

    19,000

     

    150,000

     

    (131,000

    )

    -87

    %

    Total revenue

    $

    50,192,000

    $

    75,375,000

    $

    (25,183,000

    )

    -33

    %

    Business Highlights and Developments

    BNI - Bitcoin Mining

    BitNile's Bitcoin mining is currently operating at an estimated annualized run rate of 715 Bitcoin based on current market conditions, including a mining difficulty of 28.35 trillion.

    BNI has increased its miner count to 11,949 S19j Pro Antminers and 312 S19 XP Antminers in its possession, including those units in the hands of its carrier in route to its facilities, and once installed will generate a combined processing power of approximately 1.24 exahashes per second, the computational power that is being used to mine Bitcoin. During the month of July 2022, BNI self-mined 59.9 Bitcoin. To date, BNI has mined a total of approximately 360 Bitcoin. As of August 22, 2022, BNI held approximately 240 Bitcoin and currently has no plans to sell.

    On August 15, 2022, BNI entered into a hosting agreement with Compute North, LLC ("Compute North") to host 6,500 S19j Pro Antminers owned by BNI for a period of five years. BNI granted Compute North a continuing first-position security interest in the hosted miners, as collateral for its obligations under the hosting agreement.

    As previously disclosed, BitNile has entered into purchase agreements with Bitmain Technologies Limited for a total of 20,600 Bitcoin miners, including 4,600 environmentally friendly S19 XP Antminers that feature a processing power of 140 terahashes per second ("TH/s") and 16,000 S19j Pro Antminers that feature a processing power of 100 TH/s.

    BitNile expects to receive all of the 20,600 miners by the end of 2022. Once fully deployed and operational, BitNile is expected to achieve mining production capacity of approximately 2.24 exahashes per second.

    The Company notes that all estimates and other projections are subject to the actual delivery and installation of Bitcoin miners, the volatility in Bitcoin market price, the fluctuation in the mining difficulty level, and other factors that may impact the results of production or operations.

    Acquisition of The Singing Machine Company, Inc. ("SMC")

    Beginning in June 2022, the Company, through its subsidiary Digital Power Lending, LLC ("DP Lending"), began making open market purchases of SMC common stock. These purchases granted the Company a greater than 20% effective ownership on June 9, 2022, and subsequently, on June 15, 2022, the Company owned more than 50% of the issued and outstanding common stock of SMC. The Company's ownership of SMC stood at 51.6% as of June 30, 2022.

    SMC is primarily engaged in the development, marketing, and sale of consumer karaoke audio equipment, accessories and musical recordings. SMC is the leading global karaoke and music entertainment company that specializes in the design and production of quality karaoke and music enabled consumer products for adults and children. SMC's products are among the most widely available karaoke products in the world.

    The Company consolidates the results of SMC on a one-quarter lag as it enables the Company to report its quarterly results independent from the timing of when SMC reports its results, therefore the Company's statements of operations for the three and six months ended June 30, 2022 do not include results for SMC.

    GWW and Giga-tronics Incorporated (OTC:GIGA) ("GIGA") Transaction

    GWW's proposed transaction with GIGA continues to move forward and GIGA recently filed a definitive proxy statement relating to the proposed share exchange. GWW and GIGA expect to close this acquisition, subject to fulfillment of all closing conditions, including GIGA shareholder approval, after the September 7, 2022 special meeting of GIGA shareholders. This is a significant transaction, expected to generate synergies that will enhance the positioning of the GWW defense business. The combination will add scale, production capacity, engineering expertise and global reach. The combined entity will have over 500 customers with over 40 Tier-1 prime contractors and access to more than 20 global defense ministry programs. Finally, as a combined public entity, GIGA and GWW will have the scale to pursue an uplisting to Nasdaq.

    TurnOnGreen Securities Purchase Agreement with Imperalis Holding Corp. (OTC:IMHC) ("Imperalis")

    On March 21, 2022, BitNile announced that it and TurnOnGreen entered into a securities purchase agreement with Imperalis, a publicly traded subsidiary of BitNile, whereby TurnOnGreen will, upon closing, become a subsidiary of Imperalis (the "Acquisition").

    Upon completion of the Acquisition, which is contingent upon the completion of an audit of TurnOnGreen, and each party's satisfaction or waiver of certain customary closing conditions set forth in the securities purchase agreement, Imperalis will change its name to TurnOnGreen and, through an upstream merger whereby the current TurnOnGreen shall cease to exist, have two operating subsidiaries, TOG Technologies Inc. and Digital Power Corporation. Following the closing of the Acquisition, Imperalis will dissolve its dormant subsidiary. Subsequent to the Acquisition, BitNile will assist TurnOnGreen in pursuing an uplisting to Nasdaq, subject to Nasdaq's seasoning rules and other criteria for listing.

    After completion of the Acquisition, the Company anticipates that stockholders of BitNile will receive a dividend of securities of TurnOnGreen. BitNile expects to distribute to BitNile stockholders approximately 140 million shares of Imperalis common shares and an equal number of warrants to purchase additional shares of Imperalis common stock.

    The Company's Chief Financial Officer, Kenneth S. Cragun, said, "Based on $50 million revenues reported in the first half of 2022, we enter the second half of the year on a $100 million annualized revenue run rate. In June 2022, we acquired SMC, a Nasdaq company that recently reported annual revenue for their year ended March 2022 of $47.5 million, with positive net income. We expect to see continued growth in our Bitcoin mining business as we begin the process of placing in service S19 XP Antminers at our Michigan Data Center and with the recently announced agreement with Compute North to host 6,500 of our new S19j Pro Antminers. Accordingly, we expect that our investment in SMC and our cryptocurrency mining operations will contribute to revenue growth above the current $100 million annualized revenue run rate and improved profitability in future periods."

    Milton "Todd" Ault, III, the Company's Executive Chairman, stated, "We are encouraged by our recent progress on several key initiatives. We welcome The Singing Machine Company to the BitNile family of companies. We expect the GWW and GIGA share exchange to be completed in September, adding scale to what will soon be a publicly traded defense business. We also expect to bring TurnOnGreen public by combining two of our subsidiaries, TurnOnGreen and Imperalis. Our balance sheet remains strong, reporting $51 million in working capital and growing our assets by $77 million during the second quarter to $596 million in assets. We have experienced tremendous volatility in our financial results and expect to continue to experience volatility, particularly in revenues from lending and trading activities as we mark our investment positions to the market each quarter. We also experienced a significant decline in the price of Bitcoin which has affected our topline growth. We continue to remain bullish on Bitcoin and committed to building out our mining operations in Michigan and expanding our mining footprint with Compute North in Texas."

    For more information on BitNile and its subsidiaries, BitNile recommends that stockholders, investors, and any other interested parties read BitNile's public filings and press releases available under the Investor Relations section at www.BitNile.com or available at www.sec.gov.

    About BitNile Holdings, Inc.

    BitNile Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, BitNile owns and operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, automotive, medical/biopharma, karaoke audio equipment, hotel operations and textiles. In addition, BitNile extends credit to select entrepreneurial businesses through a licensed lending subsidiary. BitNile's headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141; www.BitNile.com.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential," or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

    Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company's business and financial results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company's website at www.BitNile.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005382/en/

    Get the next $ALZN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ALZN
    $NILE

    CompanyDatePrice TargetRatingAnalyst
    Alzamend Neuro Inc.
    $ALZN
    10/1/2021$8.00Buy
    Ascendiant Capital Markets
    More analyst ratings

    $ALZN
    $NILE
    SEC Filings

    See more
    • Amendment: SEC Form 144/A filed by Alzamend Neuro Inc.

      144/A - Alzamend Neuro, Inc. (0001677077) (Subject)

      7/11/25 7:15:38 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Alzamend Neuro Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Alzamend Neuro, Inc. (0001677077) (Filer)

      7/9/25 4:30:40 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 144 filed by Alzamend Neuro Inc.

      144 - Alzamend Neuro, Inc. (0001677077) (Subject)

      5/9/25 7:49:16 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Horne William B. bought $3,285 worth of shares (3,334 units at $0.99), increasing direct ownership by 13% to 30,000 units (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      3/27/25 7:30:10 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ault Milton C Iii bought $2,969 worth of shares (2,905 units at $1.02) (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      3/25/25 4:30:07 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Financial Officer Katzoff David J bought $5,048 worth of shares (5,000 units at $1.01), increasing direct ownership by 926% to 5,540 units (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      3/24/25 7:30:07 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ascendiant Capital Markets initiated coverage on Alzamend Neuro with a new price target

      Ascendiant Capital Markets initiated coverage of Alzamend Neuro with a rating of Buy and set a new price target of $8.00

      10/1/21 7:11:54 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

      ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), today announced that it has completed the final closing of its $5 million private placement. As previously reported, on February 28, 2025, Alzamend entered into a Securities Purchase & Exchange Agreement (the "Agreement") with a sophisticated investor (the "Investor"), pursuant to which Alzamend agreed to sell to the Investor up to 500 shares of Series C Conver

      6/16/25 8:00:00 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

      Topline data expected by year endHead-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), today announced the dosing of the first patient of its first Phase II clinical study of AL001, in healthy human subjects. This study follows th

      5/29/25 8:00:00 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

      Topline data expected by year endHead-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA, May 19, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), today announced the enrollment of the first patient of its first Phase II clinical study of AL001, in healthy human subjects. This study follow

      5/19/25 8:00:00 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ault Milton C Iii sold $6,196 worth of shares (1,224 units at $5.06), decreasing direct ownership by 0.59% to 1,843 units (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      5/14/25 5:00:07 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Horne William B. bought $3,285 worth of shares (3,334 units at $0.99), increasing direct ownership by 13% to 30,000 units (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      3/27/25 7:30:10 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ault Milton C Iii bought $2,969 worth of shares (2,905 units at $1.02) (SEC Form 4)

      4 - Alzamend Neuro, Inc. (0001677077) (Issuer)

      3/25/25 4:30:07 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Leadership Updates

    Live Leadership Updates

    See more
    • BitNile Holdings Announces Results of Annual Meeting of Stockholders

      BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), announced the results of the Company's 2022 Annual Meeting of Stockholders (the "Meeting"), which was held today, November 23, 2022, at 9:00 a.m. PT, and at which time the nominees for election as directors set forth in Proposal 1 were each re-elected and Proposals 2, 3, 6 and 7 were each approved by the stockholders. Proposals 4 and 5 were not approved by the stockholders. At the Meeting, the stockholders voted upon and approved the following proposals as described in the Proxy Statement: Election of the seven director nominees named in the Proxy Statement to hold office until the next annual

      11/23/22 12:11:00 PM ET
      $NILE
      Military/Government/Technical
      Industrials
    • BitNile, Inc. to Launch Innovative Bitcoin Marketplace Platform Intended to Reimagine Cryptocurrency Transactions

      Company Appoints Veteran Developer Douglas Gintz as President and Chief Product Officer to Lead the Effort BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), announced today that its subsidiary, BitNile, Inc. ("BNI"), has begun development of a Bitcoin-based marketplace platform ("Marketplace"), which expects to leverage blockchain and other emerging technologies. BNI believes that the Marketplace will reduce the complexity of transacting in Bitcoin and result in lower transaction fees than traditional e-commerce. The Marketplace, planned for release in the first half of 2023, will be a multi-vendor e-commerce platform supporting a wide array of

      10/13/22 6:30:00 AM ET
      $NILE
      Military/Government/Technical
      Industrials
    • Alzamend Neuro Appoints Dr. Terri Hunter to Its Scientific Advisory Board

      Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, today announced the appointment of Dr. Terri Hunter, Ph.D., a Technology Transfer Specialist, to its Scientific Advisory Board. During her tenure at the University of South Florida ("USF"), Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend's two product candidates, AL001 and AL002. AL001 is a novel lithium-delivery system; it is a lithium-salicylate-L-proline engineered ionic co-crystal under development as an oral treatment for patients with demen

      4/4/22 8:00:00 AM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALZN
    $NILE
    Financials

    Live finance-specific insights

    See more
    • Ault Alpha Has Purchased 50 Million Shares of Common Stock of BitNile Holdings, Inc.

      BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), announced today that its related party, Ault Alpha, LP ("Ault Alpha"), has purchased an aggregate of 50 million shares of common stock of BitNile since it first started buying in September 2021. Ault Alpha purchases common stock of BitNile pursuant to a plan previously adopted pursuant to Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The 50 million shares of common stock represent approximately 13% of the Company as of today. "BitNile reported approximately $610 million in total assets as of September 30, 2022 and recently completed the acquisition of Circle 8,

      12/30/22 6:30:00 AM ET
      $NILE
      Military/Government/Technical
      Industrials
    • BitNile Holdings Announces Postponement of the Distribution of Securities of Imperalis Holding

      BitNile still intends to distribute to its stockholders 140 million shares and warrants to purchase an additional 140 million shares of Imperalis BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), announced today that the record date for the stock dividend for the spinoff of Imperalis Holding, to be renamed TurnOnGreen ("TurnOnGreen"), which was previously set for January 17, 2023, has been cancelled until further notice. On November 22, 2022, the Company's Board of Directors declared a pro rata dividend to the stockholders of BitNile of (i) 140 million shares of common stock of TurnOnGreen, which represent approximately 81% of the outstanding s

      12/28/22 1:47:00 PM ET
      $NILE
      Military/Government/Technical
      Industrials
    • BitNile Holdings Announces Change of Record Date for Stock Distribution for Spinoff of Securities of Imperalis Holding

      Record Date Has Been Changed to January 17, 2023 with a distribution date of January 23, 2023 BitNile to distribute to its stockholders 140 million shares and warrants to purchase an additional 140 million shares of Imperalis BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company"), announced today that the record date for the stock dividend for the spinoff of Imperalis Holding, to be renamed TurnOnGreen ("TurnOnGreen"), has been changed to January 17, 2023. The Company's Board of Directors in November declared a pro rata dividend to the stockholders of BitNile of (i) 140 million shares of common stock of TurnOnGreen, which represents approximately 81

      12/22/22 6:30:00 AM ET
      $NILE
      Military/Government/Technical
      Industrials

    $ALZN
    $NILE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Alzamend Neuro Inc. (Amendment)

      SC 13D/A - Alzamend Neuro, Inc. (0001677077) (Subject)

      2/2/24 4:38:42 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by Alzamend Neuro Inc. (Amendment)

      SC 13D/A - Alzamend Neuro, Inc. (0001677077) (Subject)

      1/25/24 5:21:29 PM ET
      $ALZN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by BitNile Holdings Inc. (Amendment)

      SC 13D/A - Ault Alliance, Inc. (0000896493) (Subject)

      10/24/23 4:30:13 PM ET
      $NILE
      Military/Government/Technical
      Industrials